STAT+: J&J sues a behind-the-scenes company for exploiting its patient assistance program

“This legal action is another reminder of how abusive insurance practices make medicines unaffordable for patients,” the Pharmaceutical Research and Manufacturers of America argued.

In the latest dust-up over prescription drug pricing, Johnson & Johnson filed a lawsuit accusing a behind-the-scenes company of exploiting a financial assistance program that is designed to help patients afford out-of-pocket costs for some of its most expensive medications.

The health care giant alleged the company, called SaveOnSP, devised a scheme that caused it to pay at least $100 million more in copayment assistance than it would have otherwise. The J&J program, which is called Janssen CarePath, attempts to help patients pay for 44 medicines, many of which are prescribed for treating cancer or auto-immune disorders, such as rheumatoid arthritis.

Continue to STAT+ to read the full story…